Abcam vs Evozyne
Abcam vs Evozyne, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abcam is on 61/100 and Evozyne on 55/100.
Where each one leads
Abcam
- our overall score: 61/100 against 55/100
- domain rating: 72/100 against 31/100
- funding raised: $257M against $135M
Evozyne
- agent readiness: 39/100 against 22/100
At a glance
| Measure | Abcam | Evozyne |
|---|---|---|
| What it is | Global supplier of life science research tools, including antibodies, reagents, and assays. | AI-driven biotech company engineering novel proteins for therapeutics and sustainability. |
| Category | Biotechnology, Life Sciences, Discovery Tools, Antibodies | Biotechnology, AI, Drug Discovery, Generative AI |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 1998 | 2020 |
| Headquarters | Cambridge, United Kingdom | Chicago, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Abcam | Evozyne |
|---|---|---|
| Employees | Not published | 54 |
| Total funding | $257M | $135M |
| Latest round | Series D | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Abcam | Evozyne |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 55/100 |
| Traction | 40/100 | 57/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | 8/100 |
| Search visibility | 16/100 | 9/100 |
| Quality | 78/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 72/100 | 31/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Abcam | Evozyne |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Abcam vs Evozyne: common questions
Which is better, Abcam or Evozyne?
On our 0-100 score Abcam rates higher (61/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Abcam and Evozyne compare on the numbers?
Abcam leads on our overall score (61/100 against 55/100), domain rating (72/100 against 31/100), funding raised ($257M against $135M). Evozyne leads on agent readiness (39/100 against 22/100).
Read the full Abcam review and pricing or the Evozyne review and pricing. You can also browse other Abcam alternatives we track.